La declaratoria de interés público del medicamento Imatinib - Glivec, configura un responsabilidad internacional
CONTENIDO DE LIBRE ACCESO
Este contenido es de libre acceso. Solo haz clic en el siguiente botón.
Ir a este contenido- Autor
- Año de publicación 2020
- Idioma Español
- Publicado por Bogotá : Universidad Externado de Colombia, 2020.
- Descripción
- The case under study corresponds to the release of Patent No. 29270, granted to the company NOVARTIS regarding the drug IMATINIB - GLIVEC, a drug used for the treatment of Chronic Myeloid Leukemia (CML), which in addition to being an important therapeutic resource in several types of cancer, it is a first-line therapy aimed at the cells that have the mutation and not the healthy cells. This decision is based on the high cost of the IMATINIB drug for the health system, which reflects a high impact of this medicine on the financia! viability of the health system. Novartis multinational Switzertand is a foreign investor in Colombia. This means that it is covered by a bilateral treaty that the two countries signed in 2006 on reciprocal investment protection. Consequently, specific obligations are assumed regarding the safeguarding of the interests of Swiss companies operating in their territory. Therefore, Colombia undertook to prevent the acts of its authorities from affecting the rights or economic expectations of Swiss investors. Said claim must be filed befare a private arbitration tribunal, under which Colombia could face international responsibility for an internationally wrongful act, since it is a behavior attributable, according to lnternational Law, to the State and constitutes a violation of an international obligation. The thesis is to prove that if there are exceptional circumstances that legitimize the lack of fulfillment of obligations, that is; that exclude the illegality of the behavior and verify it in the facts of the specific case. The circumstance that applies to the present case is that of necessity and this investigation concludes that said exceptional circumstance is applicable in the specific case.
-
Citación recomendada (normas APA)
- Sandra Liliana Neira Cardona, "La declaratoria de interés público del medicamento Imatinib - Glivec, configura un responsabilidad internacional", -:Bogotá : Universidad Externado de Colombia, 2020., 2020. Consultado en línea en la Biblioteca Digital de Bogotá (https://www.bibliotecadigitaldebogota.gov.co/resources/3240228/), el día 2024-05-02.